Abstract
Paclitaxel drug-coated balloon (P-DCB) angioplasty is used to prevent and treat luminal restenosis. Distant embolization of paclitaxel has been documented in both human and animal studies; however, few reports of cutaneous manifestations associated with P-DCB use exist. Here we present a case of unilateral cutaneous vasculitis developing after an ipsilateral P-DCB angioplasty. Though our patient’s case spontaneously resolved without complication, this case may help reveal downstream effects of P-DCBs initially thought to be rare and provides warning of potentially serious clinical consequences associated with the widely used procedure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
